IDEXX Laboratories, Inc. vs 3M Company — how do they compare? IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B), while 3M Company trades at $183.32 (market cap $94.44B). The key difference: 3M Company is far larger — about 2× IDEXX Laboratories, Inc.'s market cap, and 3M Company pays a 1.7% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | MMM | |
|---|---|---|
Market Cap | $46.22B | $94.44B |
Sector | Health | Industrials |
52-Week High | $766.68 | $183.13 |
52-Week Low | $526.44 | $141.10 |
Enterprise Value | $47.12B | $103.67B |
Dividend Yield | — | 1.7% |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
3M (MMM) trades at $184.15, up 1.16% on the day, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings, beating estimates and raising full-year guidance, driven by growth in Safety & Industrial and Transport & Electronics segments. Financial health is solid with a net income margin of 11.9% and robust cash flow, though valuation ratios like P/E of 32.53 appear elevated. Recent news highlights innovation in high-growth verticals and a partnership with Microsoft on EBO technology.
The outlook for MMM is positive due to operational improvements and raised guidance, but risks include high valuation, ongoing litigation, and macroeconomic pressures. Analyst sentiment is mixed with a consensus price target of $173.00 below the current price, suggesting cautious optimism. Investors should weigh strong fundamentals against potential headwinds for balanced decision-making.
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →